Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Topical tofacitinib is effective and safe for treating alopecia areata.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.